Cargando…
Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3/PI3K/AKT/NF-κB signaling pathway
Dihydroartemisinin (DHA) is the first generation of naturally occurring artemisinin derivatives with antimalarial activity. Recent research showed that this drug also features immunosuppressive and anti-inflammatory properties. Autoimmune thyroiditis (AIT) is a common organ-specific autoimmune disea...
Autores principales: | Liu, Huijuan, Tian, Qin, Ai, Xiaoyu, Qin, Yuan, Cui, Zhanhong, Li, Meng, Yang, Jiahuan, Zhai, Denghui, Liu, Yanrong, Chen, Shuang, Meng, Jing, Sun, Tao, Zhou, Honggang, Yang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777751/ https://www.ncbi.nlm.nih.gov/pubmed/29383139 http://dx.doi.org/10.18632/oncotarget.22854 |
Ejemplares similares
-
Dihydroartemisinin inhibits EMT induced by platinum-based drugs via Akt–Snail pathway
por: Qin, Yuan, et al.
Publicado: (2017) -
Dihydroartemisinin inhibits catabolism in rat chondrocytes by activating autophagy via inhibition of the NF-κB pathway
por: Jiang, Li-Bo, et al.
Publicado: (2016) -
Dihydroartemisinin Attenuated Intervertebral Disc Degeneration via Inhibiting PI3K/AKT and NF-κB Signaling Pathways
por: Liao, Zhiheng, et al.
Publicado: (2022) -
Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway
por: Zhong, Weilong, et al.
Publicado: (2017) -
Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
por: Du, Wei, et al.
Publicado: (2021)